Nesbitt T, Drezner M K, Lobaugh B
J Clin Invest. 1986 Jan;77(1):181-7. doi: 10.1172/JCI112274.
Abnormal regulation of vitamin D metabolism is a feature of X-linked hypophosphatemic rickets in man and of the murine homologue of the disease in the hypophosphatemic (Hyp)-mouse. We previously reported that mutant mice have abnormally low renal 25-hydroxyvitamin D-1 alpha-hydroxylase (1 alpha-hydroxylase) activity for the prevailing degree of hypophosphatemia. To further characterize this defect, we examined whether Hyp-mouse renal 1 alpha-hydroxylase activity responds normally to other stimulatory and inhibitory controls of enzyme function. We studied stimulation by parathyroid hormone (PTH) using: (a) a calcium-deficient (0.02% Ca) diet to raise endogenous PTH; or (b) 24-h continuous infusion of 0.25 IU/h bovine PTH via osmotic minipump. In both cases enzyme activity of identically treated normal mice increased to greater levels than those attained by Hyp-mice. The relative inability of PTH to stimulate 1 alpha-hydroxylase activity is not a function of the hypophosphatemia in the Hyp-mouse since PTH-infused, phosphate-depleted normal mice sustained a level of enzyme activity greater than that of normal and Hyp-mice. In further studies we investigated inhibition of enzyme activity by using: (a) a calcium-loaded (1.2% Ca) diet to suppress endogenous PTH; or (b) 24-h continuous infusion of 0.2 ng/h 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). The 1 alpha-hydroxylase activity of normal and Hyp-mice was significantly reduced to similar absolute levels following maintenance on the calcium-loaded diet. Further, infusion of 1,25(OH)2D3 caused a comparable reduction of 1 alpha-hydroxylase activity in normal, Hyp-, and phosphate-depleted normal mice. These observations indicate that the inhibitory control of 1 alpha-hydroxylase by reduced levels of PTH or increased 1,25(OH)2D3 concentrations is intact in the mutants. However, the inability of PTH and hypophosphatemia to stimulate enzyme activity in a manner analogous to that in normal and phosphate-depleted mice indicates that a generalized defect of 1 alpha-hydroxylase regulation is manifest in Hyp-mice.
维生素D代谢的异常调节是人类X连锁低磷血症佝偻病以及低磷血症(Hyp)小鼠中该疾病的小鼠同源物的一个特征。我们之前报道,对于当前程度的低磷血症,突变小鼠的肾脏25-羟基维生素D-1α-羟化酶(1α-羟化酶)活性异常低。为了进一步描述这一缺陷,我们研究了Hyp小鼠肾脏1α-羟化酶活性是否对酶功能的其他刺激和抑制控制有正常反应。我们使用以下方法研究甲状旁腺激素(PTH)的刺激作用:(a)低钙(0.02%钙)饮食以提高内源性PTH;或(b)通过渗透微型泵以0.25 IU/h的速度连续24小时输注牛PTH。在这两种情况下,经相同处理的正常小鼠的酶活性增加到比Hyp小鼠更高的水平。PTH刺激1α-羟化酶活性的相对无能并非Hyp小鼠低磷血症的作用,因为经PTH输注、磷酸盐缺乏的正常小鼠维持的酶活性水平高于正常小鼠和Hyp小鼠。在进一步的研究中,我们使用以下方法研究酶活性的抑制作用:(a)高钙(1.2%钙)饮食以抑制内源性PTH;或(b)以0.2 ng/h的速度连续24小时输注1,25-二羟基维生素D3(1,25(OH)2D3)。在高钙饮食喂养后,正常小鼠和Hyp小鼠的1α-羟化酶活性均显著降低至相似的绝对水平。此外,输注1,25(OH)2D3导致正常小鼠、Hyp小鼠和磷酸盐缺乏的正常小鼠的1α-羟化酶活性有类似程度的降低。这些观察结果表明,在突变体中,PTH水平降低或1,25(OH)2D3浓度升高对1α-羟化酶的抑制控制是完整的。然而,PTH和低磷血症无法像在正常小鼠和磷酸盐缺乏的小鼠中那样刺激酶活性,这表明Hyp小鼠中存在1α-羟化酶调节的普遍缺陷。